JAK2 and hepatocellular carcinoma: Previous studies have demonstrated that ZZXJD induces autophagy and apoptosis in hepatocellular carcinoma cells via the AKT/mTOR and JAK2/STAT3 signaling pathways, resulting in programmed cell death and inhibition of HCC progression (Sun et al., 2022).